$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 2 3 4 5 6 ... 46 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Kramer Kelly A. | Director | Option Exercise | A | 77.47 | 7,886 | 610,928 | 7,886 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Kramer Kelly A. | Director | Option Exercise | A | 0.00 | 1,936 | 0 | 8,730 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Horning Sandra | Director | Option Exercise | A | 77.47 | 7,886 | 610,928 | 7,886 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Horning Sandra | Director | Option Exercise | A | 0.00 | 1,936 | 0 | 2,568 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 0.00 | 2,270 | 0 | 0 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 0.00 | 2,270 | 0 | 129,052 | 126.8 K to 129.1 K (+1.79 %) |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 24.30 | 650 | 15,792 | 0 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 40.56 | 12,560 | 509,434 | 0 | |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 79.23 | 13,210 | 1,046,640 | 14,644 | 27.9 K to 14.6 K (-47.43 %) |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 24.30 | 650 | 15,792 | 27,854 | 27.2 K to 27.9 K (+2.39 %) |
May 07 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 40.56 | 12,560 | 509,434 | 27,204 | 14.6 K to 27.2 K (+85.77 %) |
May 06 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 66.36 | 11,486 | 762,211 | 3,829 | |
May 06 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Sell | S | 80.09 | 12,264 | 982,220 | 11,421 | 23.7 K to 11.4 K (-51.78 %) |
May 06 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 66.36 | 11,486 | 762,211 | 23,685 | 12.2 K to 23.7 K (+94.16 %) |
May 05 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,416 | 47,426 | 0 | |
May 05 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 81.75 | 2,416 | 197,508 | 54,860 | 57.3 K to 54.9 K (-4.22 %) |
May 05 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,416 | 47,426 | 57,276 | 54.9 K to 57.3 K (+4.40 %) |
Apr 29 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 2,416 | |
Apr 29 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 79.90 | 2,413 | 192,799 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
Apr 29 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
Apr 21 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 4,829 | |
Apr 21 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 83.00 | 2,413 | 200,279 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
Apr 21 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
Apr 14 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 7,242 | |
Apr 14 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 75.90 | 2,413 | 183,147 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
Apr 14 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
Apr 07 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 9,655 | |
Apr 07 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 79.52 | 2,413 | 191,882 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
Apr 07 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
Apr 01 2020 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 62 | 0 | 7,033 | |
Apr 01 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 25 | 0 | 2,762 | |
Mar 31 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 12,068 | |
Mar 31 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 75.35 | 2,413 | 181,820 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
Mar 31 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
Mar 24 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 14,481 | |
Mar 24 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 75.27 | 2,413 | 181,627 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
Mar 24 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
Mar 17 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 16,894 | |
Mar 17 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 67.26 | 2,413 | 162,298 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
Mar 17 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | A | 0.00 | 10,370 | 0 | 18,552 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | A | 72.34 | 61,590 | 4,455,421 | 61,590 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 24.30 | 2,950 | 71,670 | 650 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 75.55 | 2,950 | 222,873 | 14,644 | 17.6 K to 14.6 K (-16.77 %) |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 24.30 | 2,950 | 71,670 | 17,594 | 14.6 K to 17.6 K (+20.14 %) |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | A | 0.00 | 12,100 | 0 | 42,120 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | A | 72.34 | 71,850 | 5,197,629 | 71,850 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 0.00 | 43,200 | 0 | 163,132 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 72.34 | 256,620 | 18,563,891 | 256,620 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 12,100 | 0 | 41,116 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | A | 72.34 | 71,850 | 5,197,629 | 71,850 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 769 | 0 | 29,016 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Payment of Exercise | F | 72.34 | 356 | 25,753 | 11,400 | 11.8 K to 11.4 K (-3.03 %) |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Buy | M | 0.00 | 769 | 0 | 11,756 | 11 K to 11.8 K (+7.00 %) |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Grant | A | 53.67 | 395 | 21,199 | 10,987 | 10.6 K to 11 K (+3.73 %) |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | A | 0.00 | 13,820 | 0 | 29,120 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | A | 72.34 | 82,120 | 5,940,561 | 82,120 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | A | 0.00 | 5,180 | 0 | 22,746 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | A | 72.34 | 17,630 | 1,275,354 | 17,630 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 1,865 | 0 | 17,566 | |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Payment of Exercise | F | 72.34 | 524 | 37,906 | 12,199 | 12.7 K to 12.2 K (-4.12 %) |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 1,865 | 0 | 12,723 | 10.9 K to 12.7 K (+17.18 %) |
Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Grant | A | 53.67 | 264 | 14,169 | 10,858 | 10.6 K to 10.9 K (+2.49 %) |
Mar 10 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 19,307 | |
Mar 10 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 77.97 | 2,413 | 188,142 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
Mar 10 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | M | 0.00 | 42,925 | 0 | 119,932 | |
Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | M | 0.00 | 11,363 | 0 | 162,857 | |
Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Payment of Exercise | F | 69.36 | 25,922 | 1,797,950 | 47,570 | 73.5 K to 47.6 K (-35.27 %) |
Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Buy | M | 0.00 | 42,925 | 0 | 73,492 | 30.6 K to 73.5 K (+140.43 %) |
Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Buy | M | 0.00 | 11,363 | 0 | 30,567 | 19.2 K to 30.6 K (+59.17 %) |
Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 71.26 | 1,100 | 78,383 | 14,644 | 15.7 K to 14.6 K (-6.99 %) |
Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 70.83 | 9,341 | 661,631 | 15,744 | 25.1 K to 15.7 K (-37.24 %) |
Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Grant | A | 53.67 | 395 | 21,199 | 25,085 | 24.7 K to 25.1 K (+1.60 %) |
Feb 25 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | M | 19.63 | 21,720 | 426,364 | 0 | |
Feb 25 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Buy | M | 19.63 | 21,720 | 426,364 | 86,579 | 64.9 K to 86.6 K (+33.49 %) |
Feb 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 24.30 | 2,950 | 71,670 | 3,600 | |
Feb 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 69.32 | 2,950 | 204,494 | 24,690 | 27.6 K to 24.7 K (-10.67 %) |
Feb 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 24.30 | 2,950 | 71,670 | 27,640 | 24.7 K to 27.6 K (+11.95 %) |
Feb 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 779 | 0 | 19,431 | |
Feb 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Payment of Exercise | F | 68.99 | 219 | 15,109 | 10,594 | 10.8 K to 10.6 K (-2.03 %) |
Feb 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 779 | 0 | 10,813 | 10 K to 10.8 K (+7.76 %) |
Feb 11 2020 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 19.63 | 21,720 | 426,364 | 0 | |
Feb 11 2020 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Sell | S | 67.72 | 21,720 | 1,470,878 | 126,782 | 148.5 K to 126.8 K (-14.63 %) |
Feb 11 2020 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 19.63 | 21,720 | 426,364 | 148,502 | 126.8 K to 148.5 K (+17.13 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 0.00 | 2,728 | 0 | 8,182 | |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 40.56 | 5,000 | 202,800 | 12,560 | |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 70.00 | 1,426 | 99,820 | 24,690 | 26.1 K to 24.7 K (-5.46 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Payment of Exercise | F | 68.21 | 1,302 | 88,809 | 26,116 | 27.4 K to 26.1 K (-4.75 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 0.00 | 2,728 | 0 | 27,418 | 24.7 K to 27.4 K (+11.05 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 68.18 | 5,000 | 340,901 | 24,690 | 29.7 K to 24.7 K (-16.84 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 40.56 | 5,000 | 202,800 | 29,690 | 24.7 K to 29.7 K (+20.25 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | M | 20.65 | 20,282 | 418,722 | 0 | |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | M | 19.63 | 21,720 | 426,364 | 0 | |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Sell | S | 69.00 | 20,282 | 1,399,458 | 97,854 | 118.1 K to 97.9 K (-17.17 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Buy | M | 20.65 | 20,282 | 418,722 | 118,136 | 97.9 K to 118.1 K (+20.73 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Sell | S | 68.12 | 21,720 | 1,479,605 | 97,854 | 119.6 K to 97.9 K (-18.16 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Buy | M | 19.63 | 21,720 | 426,364 | 119,574 | 97.9 K to 119.6 K (+22.20 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 638 | 0 | 20,210 | |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 1,228 | 0 | 20,848 | |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Payment of Exercise | F | 68.21 | 658 | 44,882 | 10,034 | 10.7 K to 10 K (-6.15 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 638 | 0 | 10,692 | 10.1 K to 10.7 K (+6.35 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 1,228 | 0 | 10,054 | 8.8 K to 10.1 K (+13.91 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 1,818 | 0 | 29,785 | |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Payment of Exercise | F | 68.21 | 599 | 40,858 | 10,592 | 11.2 K to 10.6 K (-5.35 %) |
Feb 10 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Buy | M | 0.00 | 1,818 | 0 | 11,191 | 9.4 K to 11.2 K (+19.40 %) |
Jan 31 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Grant | A | 0.00 | 19,204 | 0 | 19,204 | 0 to 19.2 K |
Jan 31 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Grant | A | 0.00 | 3,834 | 0 | 9,373 | 5.5 K to 9.4 K (+69.22 %) |
Jan 31 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Payment of Exercise | F | 64.30 | 4,587 | 294,944 | 24,690 | 29.3 K to 24.7 K (-15.67 %) |
Jan 31 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Grant | A | 0.00 | 4,126 | 0 | 29,277 | 25.2 K to 29.3 K (+16.40 %) |
Jan 31 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Grant | A | 0.00 | 8,087 | 0 | 25,151 | 17.1 K to 25.2 K (+47.39 %) |
Jan 30 2020 | GILD | GILEAD SCIENCES IN ... | Horning Sandra | Director | Option Exercise | A | 0.00 | 632 | 0 | 632 | |
Jan 30 2020 | GILD | GILEAD SCIENCES IN ... | Horning Sandra | Director | Option Exercise | A | 64.36 | 3,837 | 246,949 | 3,837 | |
Jan 06 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 24.30 | 2,950 | 71,670 | 6,550 | |
Jan 06 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 64.63 | 2,950 | 190,659 | 17,064 | 20 K to 17.1 K (-14.74 %) |
Jan 06 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 24.30 | 2,950 | 71,670 | 20,014 | 17.1 K to 20 K (+17.29 %) |
Jan 02 2020 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 67 | 0 | 6,971 | |
Jan 02 2020 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 26 | 0 | 2,738 | |
Dec 04 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 24.30 | 5,900 | 143,341 | 9,500 | |
Dec 04 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 65.77 | 5,900 | 388,043 | 17,064 | 23 K to 17.1 K (-25.69 %) |
Dec 04 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 24.30 | 5,900 | 143,341 | 22,964 | 17.1 K to 23 K (+34.58 %) |
Nov 26 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 40.56 | 15,000 | 608,400 | 17,560 | |
Nov 26 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 66.85 | 15,000 | 1,002,809 | 17,064 | 32.1 K to 17.1 K (-46.78 %) |
Nov 26 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 40.56 | 15,000 | 608,400 | 32,064 | 17.1 K to 32.1 K (+87.90 %) |
Nov 20 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 24.30 | 10,000 | 242,950 | 15,400 | |
Nov 20 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 24.30 | 10,000 | 242,950 | 25,400 | |
Nov 20 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 64.91 | 10,000 | 649,062 | 17,064 | 27.1 K to 17.1 K (-36.95 %) |
Nov 20 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 24.30 | 10,000 | 242,950 | 27,064 | 17.1 K to 27.1 K (+58.60 %) |
Nov 20 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 63.85 | 10,000 | 638,500 | 17,064 | 27.1 K to 17.1 K (-36.95 %) |
Nov 20 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 24.30 | 10,000 | 242,950 | 27,064 | 17.1 K to 27.1 K (+58.60 %) |
Nov 20 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Gift | G | 0.00 | 762 | 0 | 17,064 | 17.8 K to 17.1 K (-4.27 %) |
Nov 12 2019 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 1,133 | 0 | 3,439 | |
Nov 12 2019 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 7,650 | 0 | 28,164 | |
Nov 12 2019 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | A | 65.38 | 44,160 | 2,887,181 | 44,160 | |
Nov 12 2019 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Payment of Exercise | F | 65.38 | 521 | 34,063 | 5,539 | 6.1 K to 5.5 K (-8.60 %) |
Nov 12 2019 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Buy | M | 0.00 | 1,133 | 0 | 6,060 | 4.9 K to 6.1 K (+23.00 %) |
Nov 12 2019 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | A | 0.00 | 15,300 | 0 | 15,300 | |
Nov 12 2019 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | A | 65.38 | 88,315 | 5,774,035 | 88,315 | |
Nov 07 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 66.06 | 2,095 | 138,404 | 17,826 | 19.9 K to 17.8 K (-10.52 %) |
Nov 05 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 16.89 | 2,400 | 40,536 | 0 | |
Nov 05 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 64.52 | 4,000 | 258,099 | 19,921 | 23.9 K to 19.9 K (-16.72 %) |
Nov 05 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 16.89 | 2,400 | 40,536 | 23,921 | 21.5 K to 23.9 K (+11.15 %) |
Oct 30 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Sell | S | 63.31 | 5,677 | 359,412 | 21,521 | 27.2 K to 21.5 K (-20.87 %) |
Oct 30 2019 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Sell | S | 63.31 | 5,677 | 359,412 | 21,521 | 27.2 K to 21.5 K (-20.87 %) |
Oct 03 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | M | 0.00 | 21,527 | 0 | 2,711 | |
Oct 03 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Buy | M | 0.00 | 21,527 | 0 | 64,859 | 43.3 K to 64.9 K (+49.68 %) |
Sep 30 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 68 | 0 | 6,904 | |
Sep 30 2019 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 68 | 0 | 6,904 | |
Sep 30 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 240 | 0 | 24,239 | |
Sep 30 2019 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 240 | 0 | 24,239 |